nypost.com
Open in
urlscan Pro
192.0.66.32
Public Scan
URL:
https://nypost.com/2023/12/10/lifestyle/ozempic-could-help-curb-alcohol-abuse-study-reveals/
Submission: On January 16 via manual from US — Scanned from US
Submission: On January 16 via manual from US — Scanned from US
Form analysis 2 forms found in the DOM
<form class="search__form">
<div class="search__inner" role="search">
<label for="search-input-header" class="screen-reader-text"> Search </label>
<input type="search" name="s" class="search__input" id="search-input-header" placeholder="Type to Search" tabindex="-1" data-search-header="input">
</div>
<button class="search__submit" type="submit" tabindex="-1" aria-label="Click to Search" data-search-header="submit">
<span class="search__submit-text">Search</span>
</button>
</form><form class="inline-module__form newsletter-form" data-nypost-editor="newsletter-block">
<div class="newsletter-form__wrapper">
<div class="floating-label input-container input-container--floating-label">
<input type="hidden" name="site_id" value="nypost">
<input type="hidden" id="_newsletter_nonce" name="_newsletter_nonce" value="9068f99e0e"><input type="hidden" name="_wp_http_referer" value="/2023/12/10/lifestyle/ozempic-could-help-curb-alcohol-abuse-study-reveals/"> <input type="hidden"
name="list_id" value="52710">
<input type="email" id="newsletter-block-email-65a6bd420c216" class="floating-label__input " name="email" placeholder=" ">
<div class="floating-label__label-wrap">
<label for="email" class="floating-label__label">Enter your email address</label>
</div>
</div>
<p class="newsletter-form__error">
<svg width="15" height="15">
<path
d="M7.5 0A7.5 7.5 0 1 0 15 7.5 7.5 7.5 0 0 0 7.5 0Zm.62 3.952-.112 4.15a.516.516 0 0 1-.508.534.516.516 0 0 1-.508-.534l-.112-4.15a.621.621 0 0 1 .62-.635.621.621 0 0 1 .625.635Zm-.62 7.082a.664.664 0 1 1 .689-.663.67.67 0 0 1-.689.663Z"
fill="#e13131"></path>
</svg>
<span class="error_msg"> Please provide a valid email address. </span>
</p>
<input type="submit" value="Sign Up" class="submit"
data-ga-event="
{"category":"Inline Newsletter Module Morning Report","action":"Button Click","label":"https:\/\/nypost.com\/2023\/12\/10\/lifestyle\/ozempic-could-help-curb-alcohol-abuse-study-reveals\/"} " data-ga4-event="
{"event_name":"ux_engagement","source_unit":"Inline Newsletter Module Morning Report","source_position":"Button Click"} ">
<div class="newsletter-form__notice">
<p class="t-color-black m-bottom-none"> By clicking above you agree to the <a href="/terms">Terms of Use</a> and <a href="/privacy">Privacy Policy</a>. </p>
</div>
</div>
<div class="newsletter-form__success">
<p class="inline-module__cta">
<strong>Thanks for signing up!</strong>
<br> Never miss a story.
</p>
<div class="t-center">
<a href="https://email.nypost.com/">
<span>Check out more newsletters</span>
</a>
</div>
</div>
<input type="checkbox" name="nyp_phone" value="1" style="display:none !important" tabindex="-1" autocomplete="off">
</form>Text Content
Primary Menu Sections
* News
* Metro
* Page Six
* Sports Open sub menu
* NFL
* MLB
* NBA
* NHL
* College Football
* College Basketball
* Post Sports+
* Sports Betting
* Business Open sub menu
* Personal Finance
* Opinion
* Entertainment Open sub menu
* TV
* Movies
* Music
* Celebrities
* Awards
* Theater
* Shopping
* Lifestyle Open sub menu
* Weird But True
* Health
* Sex & Relationships
* Viral Trends
* Human Interest
* Parenting
* Fashion & Beauty
* Food & Drink
* Travel
* Real Estate
* Media
* Tech
* Astrology
* Video
* Photos
* Visual Stories
* Sub Menu 1
* Today’s Paper
* Covers
* Columnists
* Horoscopes
* Crosswords & Games
* Sports Odds
* Podcasts
* Careers
* Sub menu 2
* Email Newsletters
* Official Store
* Home Delivery
* Tips
Log In
Search Email
New York Post
Log In
Open main lifestyle navigation Lifestyle
* Lifestyle
* Weird But True
* Health
* Sex & Relationships
* Viral Trends
* Human Interest
* Astrology
* Parenting
* Shopping
* Fashion & Beauty
* Food & Drink
* Travel
* Health
* Fitness
* Health Care
* Medicine
* Men’s Health
* Women’s Health
* Mental Health
* Nutrition
Search
Search
TRENDING NOW IN LIFESTYLE
Skip to main content
I DIDN'T KNOW I WAS HAVING AN AFFAIR WITH MY BEST FRIEND’S...
WEIGHT LOSS INFLUENCER DIES AT 35, LEAVING 4 KIDS AND NEW HUSBAND...
I WAS ROOMMATES WITH A VICTORIA'S SECRET MODEL — SHE KEPT...
I WON $187M IN THE LOTTERY — BUT I HAD TO DITCH MY 'DEMANDING...
THIS IS WHY YOU SHOULD SLEEP NAKED — EVEN THOUGH IT'S COLD OUT
FURIOUS PASSENGER SMACKS PILOT OVER 13-HOUR DELAY IN WILD VIDEO:...
NYC WOMAN SWEARS BY 'BEST DATING HACK' TO FIND LOVE: 'WORKS...
DEAR ABBY: I SAW MY OLD HIGH SCHOOL FLAME, SHOULD I REKINDLE...
Medicine
* Facebook
* Twitter
* Flipboard
* WhatsApp
* Email
* Copy
*
* 3535 Comments
OZEMPIC COULD HELP CURB ALCOHOL ABUSE, STUDY REVEALS
By
Angelica Stabile, Fox News
Thanks for contacting us. We've received your submission.
Back to Reading
Published Dec. 10, 2023, 11:53 a.m. ET
ORIGINALLY PUBLISHED BY:
* Ozempic diabetes and weight loss medication under investigation after a few
reports of suicidal thoughts
* Ozempic, Wegovy may be linked to stomach paralysis and other digestive issues
in large-scale study
* Ozempic, Wegovy and all those crazy, vivid dreams: Is there a connection?
The latest weight loss craze could also help people control their drinking.
Semaglutide treatments such as Ozempic and Wegovy have been shown to reduce the
symptoms of alcohol use disorder (AUD), according to a study published in The
Journal of Clinical Psychiatry on Nov. 27.
The collaborative study from The University of Oklahoma (OU) and Oklahoma State
University (OSU) found a “significant and noteworthy decrease” in the Alcohol
Use Disorders Identification Test (AUDIT) scores of six patients who were
receiving semaglutide treatment for weight loss.
Lead study author Dr. Jesse Richards, director of obesity medicine and assistant
professor of medicine at the OU-TU School of Community Medicine, said the study
was inspired by his conversation with Dr. Kyle Simmons, professor of
pharmacology and physiology at the OSU Center for Health Sciences.
“I had been hearing from a significant number of patients that their alcohol
intake was spontaneously decreasing while [they were] on the medication,”
Richards told Fox News Digital.
As a bariatric surgery clinic employee, Richards noted that it’s standard to
screen patients for alcohol use.
5
Studies found that there was a decrease in Alcohol Use Disorders Identification
Test (AUDIT) scores for six patients receiving weight-loss treatments. AP
At the clinic, a number of patients tested positive for alcohol consumption,
sometimes in concerning amounts.
Later, while on semaglutide medication, they reported reduced alcohol intake.
One of Richards’ patients — who previously drank large amounts of alcohol —
shared a new inability to drink more than two cans of beer now because it “just
doesn’t sound good.”
5
After semaglutide medication, a patient who formerly drank beer regularly began
to think that alcohol just didn’t “sound good.” Getty Images
This response piqued Richards’ interest in learning more about patients’
aversion to alcohol, which directly correlated to his research.
SEE ALSO
‘OZEMPIC TREE, OH HOW I’D LOVE TO BE SKINNY’: WE DECORATED OUR TREE WITH NEEDLES
INSTEAD OF ORNAMENTS
Research has shown that this effect is “mediated through adjustments in the
reward pathway in the brain,” he said.
“The GLP-1s are actually modifying dopamine, decreasing the craving and
decreasing the motivation to acquire things in that compulsive intake category.”
The most surprising takeaway from the study, Richards said, was that the same
significant treatment response was seen even at very low doses.
“We found that even patients on the lowest dose of semaglutide — a quarter
milligram — had a quite significant and relatively … quick onset reduction in
alcohol intake,” he said.
Of the six patients studied, all but one were on low doses — from a quarter to a
half milligram.
“And that’s very encouraging because we know that the lower doses of these
medications are tolerated much better,” said Richards.
While the results seem promising, the doctor said he does not recommend that
patients use semaglutide treatments for alcohol use disorder at this time, due
to supply and safety issues.
“If patients have [obesity and diabetes] indications for the medication and they
also struggle with alcohol intake … having them on this treatment may
potentially be beneficial,” Richards said.
5
Due to medication shortages and a lack of long-term data, it may not be
advisable to take Ozempic to target alcoholism specifically. NurPhoto via Getty
Images
“But because there has been a global medication shortage, and because we don’t
have prospective trials and don’t know what the specific safety is versus the
well-established safety data in obesity and diabetes, [I] would not recommend it
just for patients who have AUD.”
There are three FDA-approved drugs available for alcoholic use disorder that are
currently underused, the doctor noted.
Given that five million people in the U.S. are currently taking semaglutide
medications, if it is proven that those drugs have a significant effect on
alcohol use disorder, “by default, they are going to become the most widely used
drug to improve these symptoms — just by virtue of the fact that so many people
are on them for diabetes or obesity,” Richards noted.
5
Trials are underway to gather more information on the weight-loss medication and
its effect on alcohol intake. UCG/Universal Images Group via G
He confirmed that additional research is underway with two ongoing trials.
“Since we were able to show clinically meaningful reductions in alcohol intake
and AUD symptomatology in a real-world setting, that bodes very well for these
types of medications,” he said.
Looking ahead, Richard said there is a need for higher-quality evidence of the
medication’s impact on AUD compared to placebo drugs or environmental factors.
5
People struggling with alcohol use should speak with their healthcare provider.
Getty Images
Even though it’s unclear whether GLP-1 producers will market the medication to
AUD patients in the future, Richards said this could become an “established
medical practice once the safety and efficacy has been determined.”
For patients who struggle with AUD, Richards recommended they talk to their
health care providers about available treatment.
START YOUR DAY WITH ALL YOU NEED TO KNOW
Morning Report delivers the latest news, videos, photos and more.
Enter your email address
Please provide a valid email address.
By clicking above you agree to the Terms of Use and Privacy Policy.
Thanks for signing up!
Never miss a story.
Check out more newsletters
He also alerted patients that if they experience a reduced appetite and usually
consume “a bunch of calories” in alcohol, it may be necessary to look into a
more balanced diet.
Avantika Waring, 9amHealth’s chief medical officer and a trained physician and
endocrinologist in San Francisco, applauded the OU and OSU study findings for
further supporting what clinicians “are already seeing in practice,” she told
Fox News Digital.
“GLP-1 medications have a lot of effects that we are still learning about, and
the ability to decrease cravings and the reward signals related to alcohol use
are just some of the benefits,” she said.
“It’s an important starting point for further clinical trials,” she added.
Waring also warned that GLP-1 medications should not be used to treat AUD
specifically, as they can cause side effects such as nausea and changes in
appetite.
“People struggling with alcohol use disorder should consult with their
physicians before starting GLP-1 medications to make sure that they can stay
hydrated and safe on therapy,” she said.
35
What do you think? Post a comment.
Waring noted that if ongoing clinical trials find semaglutide treatments to be
effective for AUD, the medical community will “have another tool to help people
living with alcohol addiction and we’ll see expanded use of these already
popular drugs.”
Fox News Digital reached out to Novo Nordisk for comment on the potential link
between semaglutide medications and alcohol use disorder.
SHARE THIS ARTICLE:
* Facebook
* Twitter
* Flipboard
* WhatsApp
* Email
* Copy
*
* 3535 Comments
Filed under
* alcoholism
* ozempic
* weight loss
* 12/10/23
Read Next Alzheimer’s blood test could hit the market in early 202...
Sponsored
SPONSORED STORIES
Around The Web
Amy Schumer Shows Off Weight Transformation In Topless SelfiePageSix.com
Jill Biden's Ex-Husband Makes A Stunning Claim About The BidensNYPost.com
We Now Know Who Was Behind The Tom & Gisele DivorceNYPost.com
Gisele's Massive Reaction To Tom Brady's New Romance Turns HeadsPageSix.com
Here's What All Of Taylor Swift's Exes Have Said About HerNickiSwift.com
Barron Trump's Staggering Height Transformation Is A Must-SeeNickiSwift.com
Nude Scenes That Caused Big Problems Off-ScreenLooper.com
Disgraced Theranos Founder Holmes Gets Early Prison Release DateOxygen.com
All Of Gypsy Rose Blanchard's Unnecessary Medical ProceduresOxygen.com
Powered by ZergNet
TOP CONCERTS
Vividseats: Official Ticketing Partner of New York Post Get seats. Earn rewards.
Experience it live.
* Taylor Swift
71 Shows | Get Tickets
* Zach Bryan
85 Shows | Get Tickets
* Olivia Rodrigo
73 Shows | Get Tickets
* Rolling Stones
20 Shows | Get Tickets
* U2
15 Shows | Get Tickets
See More Shows
TRENDING NOW ON NYPOST.COM
* This story has been shared 131,055 times. 131,055
JASON KELCE MAKES DECISION ON HIS FUTURE AFTER EAGLES' PLAYOFF LOSS
* This story has been shared 99,963 times. 99,963
EMERGENCY CREWS SCRAMBLE TO WHITE HOUSE AFTER 911 CALLER SAYS IT'S ON FIRE
* This story has been shared 81,362 times. 81,362
GERMANY PREPARING FOR RUSSIA TO START WORLD WAR 3, LEAKED WAR PLANS REVEAL
* This story has been shared 69,446 times. 69,446
RHEA PERLMAN SUPPORTS EX DANNY DEVITO AT THE EMMYS AFTER SAYING SHE'LL NEVER
DIVORCE HIM
* This story has been shared 68,467 times. 68,467
I DIDN'T KNOW I WAS HAVING AN AFFAIR WITH MY BEST FRIEND’S HUSBAND — HERE’S
HOW I FOUND OUT
WHAT TO SHOP NOW
* THE APPLE WATCH SERIES 9 IS AT ITS LOWEST PRICE OF THE YEAR ON AMAZON
* DERMATOLOGISTS SHARE THE 32 BEST ANTI-AGING SKIN CARE PRODUCTS OF 2024
* YOU COULDN'T PAY ME TO ABANDON MY CREST WHITESTRIPS — HERE'S WHY
* STAY TOASTY THIS WINTER WITH OUR LIST OF THE BEST FLEECE-LINED LEGGINGS
* WE ORDERED AND REVIEWED 21 DIFFERENT MEAL KIT BRANDS FOR 2024
LISTEN NOW
NOW ON PAGE SIX
* ‘SUMMER HOUSE’ STAR SAM FEHER CONFIRMS BREAKUP WITH KORY KEEFER: ‘HE DOESN’T
LOVE ME’
* JESSICA SIMPSON TWINS WITH DAUGHTER MAXWELL IN ANIMAL-PRINTED JACKETS
* SAVE HUNDREDS ON THE MANSUR GAVRIEL BAG STARS LIKE KATIE HOLMES LOVE
See All
NOW ON DECIDER
* ‘THE VIEW’: ANA NAVARRO AND SARA HAINES CLASH OVER WHETHER SLAVERY SHOULD
MAKE WHITE KIDS “FEEL BAD” — “I DON’T THINK IT SHOULD”
See All
VIDEO
* DR. KING'S IMPACT ON BLACK ATHLETES DURING THE CIVIL RIGHTS MOVEMENT
Studies found that there was a decrease in Alcohol Use Disorders Identification
Test (AUDIT) scores for six patients receiving weight-loss treatments. AP
After semaglutide medication, a patient who formerly drank beer regularly began
to think that alcohol just didn't "sound good." Getty Images
Due to medication shortages and a lack of long-term data, it may not be
advisable to take Ozempic to target alcoholism specifically. NurPhoto via Getty
Images
Trials are underway to gather more information on the weight-loss medication and
its effect on alcohol intake. UCG/Universal Images Group via G
People struggling with alcohol use should speak with their healthcare provider.
Getty Images
You are viewing 1 of 5 images Previous Image Next Image
Advertisement
MORE STORIES
PAGE SIX
SUZANNE SOMERS' WIDOWER SAYS 'ODD THINGS' HAPPENING AT HOME SINCE STAR'S DEATH:
'I’M A BELIEVER NOW THAT THERE IS AN AFTER LIFE'
DECIDER
*
Drew Barrymore Sobs As She Rewatches ‘The Wedding Singer,’ Sends Heartfelt
Message To…
NYPOST
JASON KELCE MAKES DECISION ON HIS FUTURE AFTER EAGLES' PLAYOFF LOSS
* Facebook
* Twitter
* Instagram
* LinkedIn
* Email
* YouTube
* Sections & Features
* News
* Metro
* Sports
* Sports Betting
* Business
* Opinion
* Entertainment
* Fashion & Beauty
* Shopping
* Lifestyle
* Real Estate
* Media
* Tech
* Health
* Travel
* Astrology
* Video
* Photos
* Visual Stories
* Alexa
* Covers
* Horoscopes
* Sports Odds
* Podcasts
* Crosswords & Games
* Columnists
* Classifieds
* Post Sports+
* Subscribe
* Articles
* Manage
* Newsletters & Feeds
* Email Newsletters
* RSS Feeds
* NY Post Official Store
* Home Delivery
* Subscribe
* Manage Subscription
* Delivery Help
* Help/Support
* About New York Post
* Customer Service
* Apps Help
* Community Guidelines
* Contact Us
* Tips
* Newsroom
* Letters to the Editor
* Licensing & Reprints
* Careers
* Vulnerability Disclosure Program
* Apps
* iPhone App
* iPad App
* Android Phone
* Android Tablet
* Advertise
* Self Service
* Media Kit
* Contact
© 2024 NYP Holdings, Inc. All Rights Reserved Terms of Use Membership Terms
Privacy Notice Sitemap
--------------------------------------------------------------------------------
Your California Privacy Rights Do Not Sell or Share My Personal
Information/Opt-Out
SHARE LINK
click to copy
This page is not available in your area.
NYP - STRICTLY NECESSARY COOKIES AND SIMILAR TECHNOLOGIES
Strictly necessary cookies are essential for the website to function correctly.
These cookies may also be used to assist in fraud prevention and security. You
can set your browser to block or alert you about these cookies, but without
them, performance of the site may be affected and you may not be able to take
full advantage of all services and/or features of the site.
STRICTLY NECESSARY COOKIES
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.
NEWSCORP.COM ANALYTICS COOKIES
We and our service providers, such as Google Analytics, use analytics cookies to
collect information about your use of the website to help create reports and
statistics on the performance of the website, which enable us to improve the way
they work. Analytics cookies collect information such as your IP address, type
of device, operating system, referring URLs, country information data and time
of page visits, and pages visited. This information allows us to identify
overall patterns of usage on the website, and help us record any difficulties
you have with website. For information about how to opt-out of Google Analytics
cookies, please use the following link: Google Analytics
SUBMIT AN ACCESS, CORRECTION OR DELETION REQUEST TO NYP PRIVACY
Residents of CA , CO, CT, UT and VA have certain other rights with respect to
their personal information. Should you wish to exercise any of those other
rights, please indicate your preferences through the “Submit Request” link
provided below.
Submit Request
DO NOT SELL OR SHARE MY PERSONAL INFORMATION ONLY FOR NYP PRINT SUBSCRIBERS
If you are a CA, CT or VA resident and currently subscribe for (or are a former
subscriber of) home delivery of the print edition of the New York Post, you may
opt out of offline third party sales by using the “Submit an Opt Out Request”
link below. (Note: this option does not apply to residents of CO or UT because
there is no home delivery service in CO or UT.) Submit an Opt Out Request
DO NOT SELL OR SHARE MY PERSONAL INFORMATION FOR NYP INTERNET AND MOBILE USERS
Do Not Sell or Share My Personal Information for NYP Internet and Mobile Users
If you do not wish for us or our third party partners such as advertising
networks and social media platforms to sell or share your personal information
to others, please click the red "Do Not Sell or Share My Personal
Information/Opt-Out” button provided below. If you access this site and/or app
from other devices or browsers, or clear your cookies on your devices or
browsers, you will need to indicate your preferences again from those devices or
browsers. Please note that after making your “Do Not Sell or Share” request, you
may still see advertising and we may continue to share personal information with
our service providers who use such information on our behalf. To learn more
about interest-based advertising across sites and additional opt-out choices,
you can visit http://optout.aboutads.info and
http://optout.networkadvertising.org.
KNEWZ - ANALYTICS COOKIES AND SIMILAR TECHNOLOGIES
We and our service providers, such as Google Analytics, use analytics cookies to
collect information about your use of the website to help create reports and
statistics on the performance of the website, which enable us to improve the way
the site works. Analytics cookies collect information such as your IP address,
type of device, operating system, referring URLs, country information data and
time of page visits, and pages visited. This information allows us to identify
overall patterns of usage on the website, and help us record any difficulties
you have with website.
KNEWZ - ADVERTISING COOKIES AND SIMILAR TECHNOLOGIES
We may also partner with our affiliated companies, social media platforms and
other third parties where those companies and platforms gather information
through advertising cookies of users of our site in order to deliver targeted
advertising campaigns or advertisements to such users while they are on those
social media platforms.
NYP - FUNCTIONALITY COOKIES AND SIMILAR TECHNOLOGIES
Functionality cookies collect information regarding your choices and preferences
(such as, your language preference, user name, or location) to provide a more
personalized online experience and show you content relevant to where you are,
such as customizing a certain webpage or remembering if we have asked you to
sign up for our Services. With mobile or other internet enabled devices,
functionality cookies may collect a unique identifier assigned to an internet
enabled device (mobile, tablet), geolocation data or other traffic information
for that device. These features help us improve your experience with the
website, for example, to determine the appropriate device location during a
session or count articles viewed.
NYP - ANALYTICS COOKIES AND SIMILAR TECHNOLOGIES
We and our service providers, such as Google Analytics, use analytics cookies to
collect information about your use of the website to help create reports and
statistics on the performance of the website, which enable us to improve the way
the site works. Analytics cookies collect information such as your IP address,
type of device, operating system, referring URLs, country information data and
time of page visits, and pages visited. This information allows us to identify
overall patterns of usage on the website, and help us record any difficulties
you have with website.
NYP - UNKNOWN
Unknown
NYP OBSOLETE
Obsolete/cookies not in use
SOCIAL MEDIA COOKIES
These cookies are set by a range of social media services that we have added to
the site to enable you to share our content with your friends and networks. They
are capable of tracking your browser across other sites and building up a
profile of your interests. This may impact the content and messages you see on
other websites you visit. If you do not allow these cookies you may not be
able to use or see these sharing tools.
TARGETING COOKIES
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
PERFORMANCE COOKIES
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
FUNCTIONAL COOKIES
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then
some or all of these services may not function properly.
NEWSCORP.COM STRICTLY NECESSARY AND FUNCTIONALITY COOKIES
Strictly necessary cookies are essential for the website to function correctly.
These cookies may be used to assist in fraud prevention, security and to enable
filling in forms. You can set your browser to block or alert you about these
cookies, but without them, some parts of the website may not work. Functionality
cookies may collect a unique identifier assigned to an internet enabled device
(mobile, tablet), geolocation data or other traffic information for that device.
These features help us improve your experience with the website, for example, to
determine the appropriate device location during a session or store language
settings.
NEWSCORP.COM - UNKNOWN COOKIES
Newscorp.com - Unknown cookies
Cookies on the newscorp.com website that show up in the scan, but were not
identified in the cookie audit of 2022.
Back Button
COOKIE LIST
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm
Before you go ...